Hearing is easy to treat as a narrow sensory issue: the television gets louder, conversation in a restaurant becomes tiring, or certain voices become harder to follow. Research over the past decade has raised a broader question. Could age-related hearing loss also be connected with cognitive decline?

The short answer is yes, there is a consistent association. The more important answer is that association does not prove that hearing loss causes dementia, and treating hearing loss has not been shown to prevent dementia in everyone. The strongest human trial so far gives us a more measured, clinically useful picture.

Why hearing and cognition might be connected

Several mechanisms are plausible. When sound is degraded, the brain may need to devote more attention to decoding speech, leaving fewer resources available for memory and other tasks. Communication difficulty can also reduce social participation. Social isolation is itself associated with poorer cognitive outcomes.

There may also be shared causes. Vascular disease, ageing biology and other health factors could affect both hearing and cognition. Brain imaging studies have reported structural and functional differences in people with hearing loss, but these findings do not establish a single pathway from reduced hearing to dementia.

These are mechanistic explanations and observational findings. They help researchers form hypotheses. They cannot tell us whether improving hearing will change a person’s long-term cognitive trajectory.

The randomised trial changed the conversation

The ACHIEVE trial was designed to test that question more directly. It enrolled 977 adults aged 70 to 84 years with untreated hearing loss and without substantial cognitive impairment. Participants were randomly assigned to a hearing intervention, including audiological counselling and hearing devices, or to a health-education program. Researchers followed cognitive performance for three years.

In the primary analysis of all participants, cognitive change was almost identical between the groups. The hearing intervention did not slow cognitive decline across the whole study population. That overall result matters and should not be replaced by a more exciting subgroup headline.

The trial had recruited people from two different sources. One group came from a long-running cardiovascular cohort and, on average, was older and had more risk factors for cognitive decline. In that higher-risk group, the hearing intervention was associated with an almost 50 per cent slower rate of cognitive decline than health education. No comparable cognitive benefit was seen in the healthier community volunteers.

This difference was part of a prespecified analysis, but it still requires care. The trial was not primarily powered to prove benefit within each recruitment group. The result suggests that baseline risk may modify the effect; it does not establish that hearing devices prevent dementia in a particular individual.

What the newer analysis adds

A 2025 secondary analysis looked beyond recruitment source and estimated each participant’s baseline risk of cognitive decline. Among those in the highest-risk quarter, decline over three years was slower in the hearing-intervention group. Participants at lower predicted risk did not show the same pattern.

This strengthens the hypothesis that hearing care may have greater cognitive relevance when several risks are already present. It remains a secondary analysis, however. Risk models can identify patterns within a trial without becoming a clinical rule. Longer follow-up is under way, and the key unanswered question is whether the observed difference persists and translates into fewer cases of cognitive impairment or dementia.

What we can say with confidence

Hearing care has value even without a dementia-prevention claim. In ACHIEVE, the intervention improved self-reported communication. Hearing also supports conversation, social connection, awareness of the environment and participation in daily life. Those outcomes matter in their own right.

The 2024 Lancet Commission includes hearing loss among potentially modifiable dementia risk factors, and current Australian Government guidance encourages protection of hearing and regular hearing checks. Population-level risk guidance is not a guarantee for an individual. Dementia has many interacting causes, and no hearing device can remove that uncertainty.

A reasonable interpretation is therefore neither “hearing aids prevent dementia” nor “hearing has nothing to do with brain health”. The evidence supports taking hearing changes seriously, while being honest about what is known. If following conversation has become more effortful, that change can be discussed with a GP or qualified hearing professional in the context of communication, function and wider health—not as a stand-alone dementia test.

How to read the next headline

When new hearing-and-cognition research appears, three questions are useful:

  • Was the study observational, or did it randomly assign an intervention?
  • Did it measure communication, a cognitive test score, a dementia diagnosis, or another outcome?
  • Was any benefit seen across the whole study population or only in a higher-risk subgroup?

Hearing health belongs in healthy-ageing care because communication and participation matter. Its role in changing cognitive decline is promising for some higher-risk older adults, but it is not yet a universal prevention claim.

Sources

Evidence note: This Insight is general education, not medical advice. It does not diagnose hearing loss or cognitive impairment, recommend a device, or predict an individual’s dementia risk.